Orexigen Therapeutics, Inc. Indenture Agreements
7 Contracts & Agreements
- OREXIGEN THERAPEUTICS, INC. asissuer U.S. BANK NATIONAL ASSOCIATION INDENTURE Dated as ofFebruary 23, 2017 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020 Table of Contents (Filed With SEC on February 24, 2017)
- SECONDSUPPLEMENTAL INDENTURE (Filed With SEC on February 17, 2017)
- OREXIGEN THERAPEUTICS, INC. asissuer U.S. BANK NATIONAL ASSOCIATION INDENTURE Dated as ofFebruary 23, 2017 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020 Table of Contents (Filed With SEC on February 17, 2017)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on December 20, 2016)
- OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as ofMarch 21, 2016 0% Convertible Senior Secured Notes due 2020... (Filed With SEC on March 25, 2016)
- OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of March[], 2016 0% Convertible Senior Secured Notes due 2020... (Filed With SEC on March 15, 2016)
- OREXIGEN THERAPEUTICS, INC. AS ISSUER 2.75% CONVERTIBLE SENIORNOTES DUE 2020 INDENTURE DATED AS OF DECEMBER 6,2013 WILMINGTON TRUST, NATIONAL ASSOCIATION AS TRUSTEE TABLE OF... (Filed With SEC on December 9, 2013)
